Davis, M J <br/><br/>
Sulphasalazine therapy in ankylosing spondylitis: its effect on disease activity, immunoglobulin A and the complex immunoglobulin A-alpha-1-antitrypsin.  [electronic resource] 

 -  British journal of rheumatology  Oct 1989 
 - 410-3 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0263-7103 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/28.5.410  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Immunoglobulin A--metabolism<br/>Male<br/>Middle Aged<br/>Spondylitis, Ankylosing--drug therapy<br/>Sulfasalazine--therapeutic use<br/>alpha 1-Antitrypsin--metabolism